Bryan Fedorak
Fondatore presso Bartesian, Inc.
Posizioni attive di Bryan Fedorak
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Bartesian, Inc.
 Bartesian, Inc. Industrial MachineryProducer Manufacturing Bartesian, Inc. engages in the creation of cocktail drinks business. It offers capsule drink-maker such as vodka, rum, tequila, margarita, and gin. The company was founded by Bryan Fedorak and Ryan Close and is headquartered in Kitchener, Canada. | Fondatore | - | - |
| Direttore Tecnico/Scientifico/R&S | - | - | |
| Amministratore Delegato | - | - | |
Metabolomic Technologies, Inc.
 Metabolomic Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Metabolomic Technologies, Inc. is a Canadian company that specializes in developing in vitro diagnostics using metabolomics. Metabolomic Technologies was founded by Haili Wang and Richard Fedorak and is based in Edmonton, CA. The company's lead product, PolypDX™, is a urine-based screening test for colorectal cancer. The company utilizes a unique metabolomics platform to identify distinct metabolic fingerprints and develop accurate diagnostic tests. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Bryan Fedorak
Statistiche
Distribuzione geografica
| Canada | 3 |
Posizioni
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Settori
| Producer Manufacturing | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Bartesian, Inc.
Bartesian, Inc. Industrial MachineryProducer Manufacturing Bartesian, Inc. engages in the creation of cocktail drinks business. It offers capsule drink-maker such as vodka, rum, tequila, margarita, and gin. The company was founded by Bryan Fedorak and Ryan Close and is headquartered in Kitchener, Canada. | Producer Manufacturing |
Metabolomic Technologies, Inc.
Metabolomic Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Metabolomic Technologies, Inc. is a Canadian company that specializes in developing in vitro diagnostics using metabolomics. Metabolomic Technologies was founded by Haili Wang and Richard Fedorak and is based in Edmonton, CA. The company's lead product, PolypDX™, is a urine-based screening test for colorectal cancer. The company utilizes a unique metabolomics platform to identify distinct metabolic fingerprints and develop accurate diagnostic tests. | Commercial Services |
- Borsa valori
- Insiders
- Bryan Fedorak
- Esperienza
